189 developer-"https:"-"https:"-"https:"-"University-of-Aberdeen" positions at Zintellect
Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
: The extensive diversity and rapid evolution of RNA viruses pose significant challenges to the development and implementation of effective vaccines and therapeutics. High mutation rates enable these viruses
-
Research Directorate (ARD) focuses on exploiting concept development, discovery, technology development, and transition of the most promising disruptive science and technology to deliver to the Army
-
laboratory complex at White Oak includes core facilities, such as flow cytometry and confocal and electron microscopy. The focus of this fellowship is to develop and apply methods to evaluate viral vaccines
-
apply biotechnological approaches to improve the health and resilience of managed honey bees. The successful candidate will contribute to research projects focused on the development of novel therapeutics
-
discoveries through scientific excellence. Research Project: Research will focus on development of bioinformatics and genomics tools to characterize the structure and function of the bovine genome and then
-
computing, software development, geospatial or time series modeling, and mathematical modeling, or other areas of interest. This opportunity represents a unique window into the food safety regulatory
-
-products into value-added food ingredients and enhance their functional, nutritional, and sensory properties through fermentation technologies. The long-term vision is to enable the development of health
-
Project: Aflatoxin, a mycotoxin produced by Aspergillus flavus and closely related fungi, contaminates crops and is a threat to food and feed safety. The overall research goal of the lab is to develop
-
generated quickly and regularly. Help develop machine learning techniques for feral swine abundance in data sparse environments. Collaborate with APHIS Wildlife Services (WS) to integrate data and model
-
responses. While most patients tolerate therapeutic products without issue, a subset develops immune-mediated adverse reactions, often driven by interactions between drug-derived or altered epitopes and the